Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NELARABINE Cause Disseminated intravascular coagulation? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Disseminated intravascular coagulation have been filed in association with NELARABINE (Nelarabine). This represents 0.8% of all adverse event reports for NELARABINE.

6
Reports of Disseminated intravascular coagulation with NELARABINE
0.8%
of all NELARABINE reports
3
Deaths
2
Hospitalizations

How Dangerous Is Disseminated intravascular coagulation From NELARABINE?

Of the 6 reports, 3 (50.0%) resulted in death, 2 (33.3%) required hospitalization, and 3 (50.0%) were considered life-threatening.

Is Disseminated intravascular coagulation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NELARABINE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does NELARABINE Cause?

Febrile neutropenia (67) Drug ineffective (50) Myelopathy (47) Neurotoxicity (47) Neuropathy peripheral (45) Muscular weakness (42) Sepsis (39) Peripheral sensory neuropathy (38) Neutropenia (37) Off label use (37)

What Other Drugs Cause Disseminated intravascular coagulation?

PREDNISOLONE (362) METHOTREXATE (347) DEXAMETHASONE (323) METHYLPREDNISOLONE (307) NIVOLUMAB (305) CYCLOPHOSPHAMIDE (286) TACROLIMUS (278) PREDNISONE (277) VINCRISTINE (245) OXALIPLATIN (231)

Which NELARABINE Alternatives Have Lower Disseminated intravascular coagulation Risk?

NELARABINE vs NELFINAVIR NELARABINE vs NELVUTAMIG NELARABINE vs NEMOLIZUMAB NELARABINE vs NEMOLIZUMAB-ILTO NELARABINE vs NEOMYCIN

Related Pages

NELARABINE Full Profile All Disseminated intravascular coagulation Reports All Drugs Causing Disseminated intravascular coagulation NELARABINE Demographics